Nightingale to roll-out novel preventative solution for COVID-19 enabling safe returns to work post lockdowns
–– Research shows blood test predicts severity of COVID-19 before contracting the virusNightingale Health , a Finnish biotech, today announced the launch of a preventative screening solution for COVID-19. The solution is based on Nightingale’s blood test that detects the likelihood of a healthy person developing a severe COVID-19 infection before contracting the virus. This allows preventative targeted actions for the ones vulnerable to the virus, whilst the rest of the working population can continue keeping societies running. The announcement follows major